This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_NASOPHARYNX_EXALLC for full statistics.
Malignant neoplasm of nasopharynx
C3_NASOPHARYNX
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
99 |
4. Check minimum number of eventsNone |
99 |
5. Include endpointsNone |
99 |
6. Filter based on genotype QC (FinnGen only) |
99 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of nasopharynx
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of nasopharynx, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of head and neck
- Malignant neoplasm of head and neck, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Any event in cancer register
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 99 | 39 | 60 |
| Unadjusted period prevalence (%) | 0.02 | 0.01 | 0.03 |
| Median age at first event (years) | 62.18 | 57.35 | 65.33 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 96
- Matched controls
- 961
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
UDH02
NOMESCO Finland
Rhinopharyngoscopy
57.9
44.5
52
19
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
183.0
42.9
42
*
JDB10
NOMESCO Finland
Percutaneous gastrostomy
214.9
40.2
39
*
8070/3-C11.9
ICD-O-3
Squamous cell carcinoma, NOS, of nasopharynx, NOS
+∞
35.7
32
*
C11.9
ICD-10 Finland
Malignant neoplasm: Nasopharynx, unspecified
+∞
32.1
29
*
130
Kela drug reimbursment
Malignant tumour
19.2
31.8
54
60
A03FA01
ATC
metoclopramide; systemic, rectal
11.4
25.5
61
127
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
+∞
23.9
22
*
C11.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of nasopharynx
+∞
22.8
21
*
WF002
NOMESCO Finland
Radical radiotherapy
17.5
21.0
34
29
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
8.2
20.3
63
180
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
22.5
19.9
29
18
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
62.3
17.8
20
*
C11.1
ICD-10 Finland
Malignant neoplasm: Posterior wall of nasopharynx
+∞
17.2
16
*
D10.6
ICD-10 Finland
Benign neoplasm: Nasopharynx
+∞
17.2
16
*
C11.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of nasopharynx
+∞
17.2
16
*
C11.0
ICD-10 Finland
Malignant neoplasm: Superior wall of nasopharynx
+∞
17.2
16
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
35.5
15.9
20
7
N02AA05
ATC
oxycodone; systemic
7.4
15.6
43
94
R22.1
ICD-10 Finland
Localized swelling, mass and lump, neck
19.7
15.4
23
15
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
43.7
15.1
18
5
UDQ12
NOMESCO Finland
Flexible laryngoscopy
11.9
14.8
28
32
EP1AE
NOMESCO Finland
Neck ultrasound examination
17.4
14.1
22
16
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
87.6
14.0
15
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
162.0
13.8
14
*
EBA10
NOMESCO Finland
Surgical removal of tooth
9.9
13.5
28
38
A04AA01
ATC
ondansetron; systemic, rectal
11.2
13.0
25
29
H65.2
ICD-10 Finland
Chronic serous otitis media
37.9
13.0
16
5
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
148.6
12.8
13
*
Z01.1
ICD-10 Finland
Examination of ears and hearing
6.3
11.1
32
70
A04AA02
ATC
granisetron; systemic, transdermal
8.8
10.6
23
33
8010/3-C11.9
ICD-O-3
Carcinoma, NOS, of nasopharynx, NOS
+∞
10.6
10
*
A07AA02
ATC
nystatin; oral
9.8
10.0
20
25
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
7.1
10.0
25
45
H02AB02
ATC
dexamethasone; systemic
5.8
9.8
30
70
XX3DW
NOMESCO Finland
Time consuming IT work
6.2
9.8
28
60
EN1BD
NOMESCO Finland
Very extensive CT examination of mouth and soft tissues of neck
33.9
9.7
12
*
DHA10
NOMESCO Finland
Biopsy of cavity of nose
110.5
9.6
10
*
ZX095
NOMESCO Finland
Combined chemoradiotherapy
110.5
9.6
10
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.8
9.5
18
20
YA1CD
NOMESCO Finland
Very extensive CT examination of head and neck for dose design of radiotherapy
+∞
9.5
9
*
JCW98
NOMESCO Finland
Other transluminal endoscopic procedure on oesophagus
+∞
9.5
9
*
WX199
NOMESCO Finland
Other local analgesia
21.2
9.2
13
7
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
3.8
8.7
52
229
UDM02
NOMESCO Finland
Sinoscopy
22.5
8.7
12
6
H65.3
ICD-10 Finland
Chronic mucoid otitis media
22.5
8.7
12
6
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
9.6
8.5
17
21
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
+∞
8.4
8
*
9680/3-C11.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of nasopharynx, NOS
+∞
8.4
8
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
19.3
8.3
12
7
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
36.8
8.3
10
*
K11.71
ICD-10 Finland
Xerostomy (dry mouth)
36.8
8.3
10
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
9.9
8.2
16
19
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
7.7
7.9
18
28
R13
ICD-10 Finland
Dysphagia
7.7
7.9
18
28
ENA10
NOMESCO Finland
Biopsy of pharynx
86.5
7.5
8
*
8070/3-C11.2
ICD-O-3
Squamous cell carcinoma, NOS, of lateral wall of nasopharynx
+∞
7.4
7
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
13.5
7.3
12
10
J01CE02
ATC
phenoxymethylpenicillin; oral
3.6
6.9
77
506
A01AB09
ATC
miconazole; local oral
6.1
6.7
18
35
H66.0
ICD-10 Finland
Acute suppurative otitis media
8.4
6.7
14
19
WF003
NOMESCO Finland
Adjuvant radiotherapy
9.2
6.6
13
16
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
15.7
6.6
10
7
SAA03
NOMESCO Finland
Extended examination of mouth
3.2
6.5
45
209
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
74.6
6.5
7
*
EP1DG
NOMESCO Finland
Very extensive examination of soft tissue of neck with high intesity magnet
19.6
6.4
9
5
8070/3-C11.1
ICD-O-3
Squamous cell carcinoma, NOS, of posterior wall of nasopharynx
+∞
6.3
6
*
8072/3-C11.9
ICD-O-3
Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of nasopharynx, NOS
+∞
6.3
6
*
SXC05
NOMESCO Finland
Other oral or dental procedure
9.6
6.3
12
14
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
16.3
6.0
9
6
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
19
5
46.36
16.05
1.3
1.0
—
—
—
0
0
13
18
8.16
9.07
1.2
1.2
—
—
—
0
0
60
344
2.89
6.17
6.0
4.7
34.1
35.8
g/l
1.20
53
323
9
6
16.30
6.02
1.3
1.7
—
—
—
0
0
71
454
2.99
5.81
17.0
10.2
4.0
4.0
e9/l
0.06
63
393
61
383
2.54
4.81
9.8
7.0
1.2
1.2
mmol/l
0.50
53
323
57
348
2.50
4.75
8.4
5.4
1.2
1.2
mmol/l
0.66
52
316
23
97
2.79
4.02
6.5
4.1
217.8
261.9
u/l
0.85
23
90
11
29
4.14
3.92
1.8
2.7
—
—
—
0
0
44
264
2.20
3.54
5.0
3.6
2.3
2.3
mmol/l
0.03
38
236
52
363
1.91
2.55
3.9
4.0
—
—
—
0
0
6
12
5.24
2.44
2.2
2.0
—
—
—
0
0
8
23
3.69
2.32
1.8
1.5
—
—
—
0
0
16
78
2.25
2.04
2.1
1.8
386.7
376.0
nmol/l
0.09
16
70
63
752
0.55
2.00
5.9
6.1
39.9
40.4
mmol/mol
0.21
54
710
21
116
2.03
1.98
1.9
2.0
—
—
—
0
0
28
175
1.84
1.84
2.4
2.5
—
—
—
0
0
64
755
0.57
1.82
4.3
4.3
1.4
1.3
mmol/l
0.26
56
697
13
61
2.30
1.81
1.8
1.7
—
—
—
0
0
6
18
3.48
1.77
2.3
2.0
—
—
—
0
0
21
122
1.92
1.72
2.8
3.0
3.2
1.6
e6/l
0.55
11
73
69
794
0.57
1.70
5.4
5.4
2.9
2.7
mmol/l
0.71
60
734
6
19
3.29
1.69
2.2
1.9
—
—
—
0
0
16
86
2.03
1.62
1.4
1.9
—
—
—
0
0
67
772
0.59
1.55
5.0
4.8
1.4
1.4
mmol/l
0.13
60
717
5
15
3.45
1.54
1.2
1.3
—
—
—
0
0
32
219
1.68
1.53
3.8
2.7
332.7
7222.5
umol/l
1.06
26
178
6
22
2.83
1.46
1.0
1.1
—
—
—
0
0
68
775
0.61
1.40
4.8
4.9
4.8
4.6
mmol/l
0.61
61
726
5
18
2.87
1.30
1.4
1.4
—
—
—
0
0
15
87
1.85
1.23
1.4
2.0
—
—
—
0
0
18
111
1.76
1.22
1.8
1.3
—
—
—
0
0
6
26
2.39
1.20
2.8
1.9
—
—
—
0
0
5
20
2.58
1.16
2.4
1.4
—
—
—
0
0
7
33
2.20
1.08
1.0
1.6
—
—
—
0
0
67
577
1.50
1.06
5.7
3.8
14.8
14.8
pmol/l
0.06
62
519
19
128
1.60
0.95
2.5
2.7
0.3
1.1
e6/l
—
8
77
69
765
0.68
0.94
4.7
5.0
6.1
6.1
mmol/l
0.01
61
707
6
29
2.14
0.91
1.3
1.2
—
—
—
0
0
5
23
2.23
0.77
1.4
1.4
—
—
—
0
0
5
23
2.23
0.77
1.6
1.5
—
—
—
0
0
5
24
2.14
0.75
1.6
1.3
—
—
—
0
0
7
39
1.85
0.74
1.0
1.8
—
—
—
0
0
21
160
1.40
0.60
4.0
3.5
22.6
125.2
ng/l
1.98
16
131
39
328
1.31
0.60
1.6
1.9
87.4
92.3
pmol/l
0.27
14
167
14
100
1.47
0.55
5.4
4.9
28.4
32.0
%
—
8
64
76
709
1.31
0.48
6.3
4.6
2.0
2.0
mu/l
0.18
71
641
18
224
0.76
0.43
4.9
3.4
0.0
0.0
estimate
—
5
77
26
308
0.79
0.42
4.3
3.5
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
9
68
1.36
0.39
2.1
4.3
5.6
5.9
kpa
—
9
62
5
36
1.41
0.39
1.6
1.5
—
—
—
0
0
26
219
1.25
0.38
3.8
3.0
0.2
0.3
e6/l
0.27
19
170
19
229
0.79
0.35
2.5
2.9
0.7
0.8
ug/l
0.54
13
141
34
384
0.83
0.35
5.1
5.2
2.4
2.1
ug/l
0.18
28
339
34
301
1.20
0.31
1.8
2.1
71.7
75.6
nmol/l
0.36
29
262
7
56
1.27
0.30
1.9
1.3
—
—
—
0
0
21
178
1.23
0.29
2.2
1.8
0.8
1.2
mg/l
0.55
14
149
8
64
1.27
0.28
6.3
4.3
1.2
1.2
mmol/l
—
8
57
36
397
0.85
0.27
4.1
3.3
0.0
0.0
estimate
—
5
77
0
10
0.00
0.21
0.0
3.6
—
—
—
0
0
32
291
1.15
0.21
3.5
3.1
—
—
—
0
0
11
131
0.82
0.18
1.2
1.2
10.3
21.1
iu/ml
—
6
43
36
387
0.89
0.17
5.7
4.5
0.0
0.0
estimate
—
5
83
13
111
1.20
0.17
6.5
8.8
—
—
—
0
0
28
305
0.89
0.16
4.3
4.5
24.5
21.0
%
0.51
12
141
7
85
0.81
0.15
6.1
3.2
—
—
—
0
0
5
47
1.07
0.09
24.8
4.4
26.0
24.7
mmol/l
—
5
47
74
755
0.92
0.08
21.8
13.8
77.9
78.2
ml/min/173m2
0.04
63
620
41
405
1.02
0.00
3.0
2.8
—
—
—
0
0
84
836
1.03
0.00
27.5
17.8
79.2
81.3
umol/l
0.30
84
836
16
161
0.99
0.00
1.6
1.6
1098.6
1307.6
nmol/l
—
10
126
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
0
7
0.00
0.00
0.0
6.3
—
122.0
—
0
7
0
7
0.00
0.00
0.0
5.1
—
—
—
0
0
0
6
0.00
0.00
0.0
6.8
—
—
—
0
0
7
71
0.98
0.00
3.0
2.8
27.4
29.5
u/l
—
7
57
0
8
0.00
0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.2
—
58.0
—
0
6
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
2.2
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
6
65
0.92
0.00
3.0
3.4
—
62.7
—
0
28
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
4.0
—
69.5
—
0
5
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_NASOPHARYNX – Malignant neoplasm of nasopharynx
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).